CA2191099A1 - Anticorps non anti-vih servant de revelateurs de maladies - Google Patents

Anticorps non anti-vih servant de revelateurs de maladies

Info

Publication number
CA2191099A1
CA2191099A1 CA 2191099 CA2191099A CA2191099A1 CA 2191099 A1 CA2191099 A1 CA 2191099A1 CA 2191099 CA2191099 CA 2191099 CA 2191099 A CA2191099 A CA 2191099A CA 2191099 A1 CA2191099 A1 CA 2191099A1
Authority
CA
Canada
Prior art keywords
disease
antibodies
antigen
antibody
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2191099
Other languages
English (en)
Inventor
Howard B. Urnovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calypte Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2191099A1 publication Critical patent/CA2191099A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne la détection d'anticorps réagissant avec des antigènes rétroviraux endogènes humains associés à divers états pathologiques. En particulier, l'invention concerne des procédés de dosage immunologiques permettant la détection de tels anticorps.
CA 2191099 1994-05-23 1995-05-23 Anticorps non anti-vih servant de revelateurs de maladies Abandoned CA2191099A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24820094A 1994-05-23 1994-05-23
US08/248,200 1994-05-23
US32168994A 1994-10-12 1994-10-12
US08/321,689 1994-10-12

Publications (1)

Publication Number Publication Date
CA2191099A1 true CA2191099A1 (fr) 1995-11-30

Family

ID=26939190

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2191099 Abandoned CA2191099A1 (fr) 1994-05-23 1995-05-23 Anticorps non anti-vih servant de revelateurs de maladies

Country Status (4)

Country Link
EP (1) EP0763137A1 (fr)
AU (1) AU2690995A (fr)
CA (1) CA2191099A1 (fr)
WO (1) WO1995032311A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6423496B1 (en) 1996-01-11 2002-07-23 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
BR9707125A (pt) * 1996-01-11 1999-07-20 Corixa Corp Composições e processos para o tratamento e diagnóstico de câncer de mama
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
US20100204149A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of octreotide as a therapeutic agent
WO2009033818A2 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent thérapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
US5320940A (en) * 1989-05-19 1994-06-14 Board Of Regents, The University Of Texas System Methods and compositions for identifying and characterizing individuals having autoimmune rheumatic diseases
ATE211168T1 (de) * 1990-05-21 2002-01-15 Univ Tulane Assoziation zwischen einem menschlichen immunschwäche-virus verwandten retrovirus und dem sjoegren-syndrom

Also Published As

Publication number Publication date
AU2690995A (en) 1995-12-18
WO1995032311A1 (fr) 1995-11-30
EP0763137A1 (fr) 1997-03-19

Similar Documents

Publication Publication Date Title
Hauser et al. Analysis of human T-lymphotropic virus sequences in multiple sclerosis tissue
CA1265442A (fr) Epreuve elisa competitive pour la detection des anticorps
JP2626721B2 (ja) Ｈｔｌｖ―３の蛋白質の分離、エイズおよび前エイズ条件を持つ患者の血清中ｈｔｌｖ―３に対する抗体の血清学的検出、およびｈｔｌｖ―３およびその蛋白質を使用した免疫分析によるｈｔｌｖ―３感染の検出
US6406841B1 (en) Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
EP0609305A1 (fr) Retrovirus humain analogue au type c lie a la sclerose en plaques
Gilbert et al. Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120
US6514691B1 (en) Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
CA2191099A1 (fr) Anticorps non anti-vih servant de revelateurs de maladies
JPH11237381A (ja) ヒトまたは動物の移植用組織をそのレシピエントに 適合させる方法及びヒトまたは動物において 腫瘍抗原を検出する方法
AU591647B2 (en) Improvements relating to viral isolates and their use
JPS62501797A (ja) ウイルス分離物に関する改良及びその使用
EP0234941A2 (fr) ELISA compétitif pour détecter les anticorps
CA2113099C (fr) Differenciation de htlv-i et de htlv-ii grace a des peptides synthetiques
Walther et al. Evaluation of HIV-1/HIV-2 immunoblots for detection of HIV-2 antibodies
EP1135684B1 (fr) SPECIFICITE AMELIOREE DE LA DETECTION D'ANTICORPS IgM ANTIRUBEOLIQUES
KR0168447B1 (ko) T-임파 친화성 레트로비루스 모노클로날 항체
De Stasio et al. Screening for anti-human T-lymphotropic virus antibody in blood donors and polytransfused patients in Apulia (Italy)
AU580425B2 (en) Competitive elisa for the detection of antibodies
Weber et al. Evaluation of the automated ‘Enzymen-Test Anti HIV-1+ 2’and ‘Enzymen-Test anti HIV-12 selective’for the combined detection and differentiation of anti-HIV-1 and anti-HIV-2 antibodies
RU2283497C1 (ru) ИММУНОФЕРМЕНТНАЯ ТЕСТ-СИСТЕМА ДЛЯ ИДЕНТИФИКАЦИИ СПЕКТРА АНТИТЕЛ К ВИЧ 1 И 2 ВЫЯВЛЕНИЯ АНТИГЕНА ВИЧ 1 (p24) "ДС-ИФА-АНТИ-ВИЧ 1 И 2, ВИЧ 1 ГРУППЫ О-СПЕКТР+АГ p24 ВИЧ 1"
Kawanishi et al. Low‐titer antibodies reactive with HTLV‐I gag P19 in patients with chronic myeloneuropathy
Tatsumi et al. Use of monoclonal antibodies for the detection and quantification of HIV1 core protein p25: Comparative evaluation of in vitro HIV1 infection by immunofluorescence, antigen capture ELISA and reverse transcriptase assays
Munene et al. Evaluation of HIV ELISA diagnostic kit developed at the Institute of Primate Research, Nairobi Kenya
Nakamura et al. Current status of clinical laboratory tests for the human immunodeficiency virus
JPH05188057A (ja) Ｈｉｖ−１抗体の免疫酵素的検出法

Legal Events

Date Code Title Description
FZDE Dead